|Dr. James J. Barry Ph.D.||Pres, CEO & Director||421.24k||N/A||58|
|Mr. Craig Shore||CFO, Chief Admin. Officer, Treasurer & Sec.||435.68k||N/A||56|
|Mr. Agustin V. Gago||Exec. VP & Chief Commercial Officer||76.22k||N/A||57|
|Dr. Sol J. Barer Ph.D.||Special Advisor to the Board||17.5k||N/A||70|
|Mr. Benzi Spector||Head of R&D and Operations||N/A||N/A||N/A|
InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex coronary and vascular diseases. It offers MGuard prime embolic protection systems for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions; and CGuard carotid embolic prevention systems for use in carotid artery applications. The company is also developing NVGuard, a neurovascular flow diverter that diverts blood flow away from cerebral aneurysms and seals the aneurysms. InspireMD, Inc. distributes its products in Europe, Latin America, the Middle East, and Asia. The company is headquartered in Tel Aviv, Israel.
InspireMD, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.